Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89

1.

Thiopurine metabolism monitoring: implications in inflammatory bowel diseases.

Dewit O, Starkel P, Roblin X.

Eur J Clin Invest. 2010 Nov;40(11):1037-47. doi: 10.1111/j.1365-2362.2010.02346.x. Epub 2010 Aug 19. Review.

PMID:
20629710
2.

On therapeutic drug monitoring of thiopurines in inflammatory bowel disease; pharmacology, pharmacogenomics, drug intolerance and clinical relevance.

Van Asseldonk DP, de Boer NK, Peters GJ, Veldkamp AI, Mulder CJ, Van Bodegraven AA.

Curr Drug Metab. 2009 Nov;10(9):981-97. Review.

PMID:
20214590
3.

Review article: thiopurines in inflammatory bowel disease.

Derijks LJ, Gilissen LP, Hooymans PM, Hommes DW.

Aliment Pharmacol Ther. 2006 Sep 1;24(5):715-29. Review.

4.

Thiopurine methyltransferase activity combined with 6-thioguanine metabolite levels predicts clinical response to thiopurines in patients with inflammatory bowel disease.

Kwan LY, Devlin SM, Mirocha JM, Papadakis KA.

Dig Liver Dis. 2008 Jun;40(6):425-32. doi: 10.1016/j.dld.2008.01.003. Epub 2008 Mar 4.

PMID:
18304898
6.

Thiopurines in inflammatory bowel disease: pharmacogenetics, therapeutic drug monitoring and clinical recommendations.

Al Hadithy AF, de Boer NK, Derijks LJ, Escher JC, Mulder CJ, Brouwers JR.

Dig Liver Dis. 2005 Apr;37(4):282-97. Review.

PMID:
15788214
7.

No induction of thiopurine methyltransferase during thiopurine treatment in inflammatory bowel disease.

Lindqvist M, Hindorf U, Almer S, Söderkvist P, Ström M, Hjortswang H, Peterson C.

Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1033-7.

PMID:
17065060
8.

Pharmacogenetics of thiopurines in inflammatory bowel disease.

Derijks LJ, Wong DR.

Curr Pharm Des. 2010;16(2):145-54. Review.

PMID:
20205660
9.

Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.

Gearry RB, Barclay ML.

J Gastroenterol Hepatol. 2005 Aug;20(8):1149-57. Review.

PMID:
16048561
10.

Thiopurine therapy in inflammatory bowel disease.

Ha C, Dassopoulos T.

Expert Rev Gastroenterol Hepatol. 2010 Oct;4(5):575-88. doi: 10.1586/egh.10.59. Review.

PMID:
20932143
11.

Use of thiopurines in inflammatory bowel disease.

Frei P, Biedermann L, Nielsen OH, Rogler G.

World J Gastroenterol. 2013 Feb 21;19(7):1040-8. doi: 10.3748/wjg.v19.i7.1040. Review.

12.

[The usefulness of pharmacogenetics for a more individualized treatment. The example thiopurines in inflammatory bowel disease and childhood leukemia].

Lindqvist Appell M, Mårtensson LG, Almer S, Peterson C.

Lakartidningen. 2015 Jun 30;112. pii: DF7L. Review. Swedish.

PMID:
26126006
13.

Meta-analysis: Inosine triphosphate pyrophosphatase polymorphisms and thiopurine toxicity in the treatment of inflammatory bowel disease.

Van Dieren JM, Hansen BE, Kuipers EJ, Nieuwenhuis EE, Van der Woude CJ.

Aliment Pharmacol Ther. 2007 Sep 1;26(5):643-52. Review.

14.

Pharmacogenomics and IBD: TPMT and thiopurines.

Sandborn WJ.

Inflamm Bowel Dis. 2004 Feb;10 Suppl 1:S35-7. Review. No abstract available.

PMID:
15168829
15.

ISIS 2302. Oligo-TCS.

[No authors listed]

Drugs R D. 1999 Mar;1(3):265-7. No abstract available.

PMID:
10566042
16.

The role of thiopurine metabolites in inflammatory bowel disease and rheumatological disorders.

Friedman AB, Sparrow MP, Gibson PR.

Int J Rheum Dis. 2014 Feb;17(2):132-41. Review.

PMID:
24618304
17.

Influences of thiopurine methyltransferase genotype and activity on thiopurine-induced leukopenia in Korean patients with inflammatory bowel disease: a retrospective cohort study.

Kim JH, Cheon JH, Hong SS, Eun CS, Byeon JS, Hong SY, Kim BY, Kwon SH, Kim SW, Han DS, Yang SK, Kim WH.

J Clin Gastroenterol. 2010 Nov-Dec;44(10):e242-8. doi: 10.1097/MCG.0b013e3181d6baf5.

PMID:
20308917
18.

Difficulties and possibilities with thiopurine therapy in inflammatory bowel disease--proceedings of the first Thiopurine Task Force meeting.

van Asseldonk DP, Sanderson J, de Boer NK, Sparrow MP, Lémann M, Ansari A, Almer SH, Florin TH, Gearry RB, Mulder CJ, Mantzaris G, van Bodegraven AA; Thiopurine Task Force Interest Group..

Dig Liver Dis. 2011 Apr;43(4):270-6. doi: 10.1016/j.dld.2010.09.001. Epub 2010 Oct 8. Review.

PMID:
20934926
19.
20.

Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?

de Boer NK, de Meij T, van Bodegraven AA.

Expert Rev Gastroenterol Hepatol. 2013 Nov;7(8):669-71. doi: 10.1586/17474124.2013.841541. Epub 2013 Oct 17. No abstract available.

PMID:
24134152

Supplemental Content

Support Center